Author:
Li Yan,Wang Kai,Jiang Yi-Zhou,Chang Xin-Wen,Dai Cai-Feng,Zheng Jing
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference45 articles.
1. T.A. Yap, C.P. Carden, S.B. Kaye, Beyond chemotherapy: targeted therapies in ovarian cancer. Nat. Rev. Cancer 9, 167–181 (2009)
2. J. Di, T. Duiveman-de Boer, P.L. Zusterzeel, C.G. Fig, L.F. Massuger, R. Torensma, The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cell. Oncol. 36, 363–374 (2013)
3. O. Krijgsman, D. Israeli, H.F. van Essen, P.P. Eijk, M.L. Berens, C.H. Mellink, A.W. Nieuwint, M.M. Weiss, R.D. Steenbergen, G.A. Meijer, B. Ylstra, Detection limits of DNA copy number alterations in heterogeneous cell populations. Cell. Oncol. 36, 27–36 (2013)
4. R.C. Jr, B. Bast, G.B.M. Hennessy, The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 9, 415–428 (2009)
5. S. Safe, A. McDougal, Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (review). Int. J. Oncol. 20, 1123–1128 (2002)
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献